Vitamin A depletion alters sensitivity of motor behavior to MK-801 in C57BL/6J mice

Behavioral and Brain Functions

Volumn 6, Issue , 2010, Pages

  Zhang, Ming ^a,b   Ji, Baohu ^a,b   Zou, Hong ^b   Shi, Junwei ^b   Zhang, Zhao ^a,b   Li, Xingwang ^a   Zhu, Hui ^a,b   Feng, Guoyin ^c   Jin, Meilei ^b   Yu, Lei ^e   He, Lin ^a,b,d   Wan, Chunling ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Chinese Academy of Sciences   (China)

^c SHANGHAI MENTAL HEALTH CENTER   (China)

^d FUDAN UNIVERSITY   (China)

^e RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIZOCILPINE; DIZOCILPINE MALEATE; RETINOL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATAXIA; C57BL 6 MOUSE; CONTROLLED STUDY; FEMALE; LOCOMOTION; MALE; MOTOR PERFORMANCE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; REARING; RETINOL DEFICIENCY; SENSITIVITY ANALYSIS; STEREOTYPY; TAIL FLICK TEST; WEIGHT REDUCTION; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; METHODOLOGY; MOTOR ACTIVITY; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; DIZOCILPINE MALEATE; FEMALE; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; MOTOR SKILLS; PAIN MEASUREMENT; VITAMIN A; VITAMIN A DEFICIENCY;

EID: 77649304846     PISSN: 17449081     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-9081-6-7     Document Type: Article

References (40)

1. Maden M. Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat Rev Neurosci 2007, 8:755-65. 10.1038/nrn2212, 17882253.
2. Lamantia AS. Forebrain induction, retinoic acid, and vulnerability to schizophrenia: insights from molecular and genetic analysis in developing mice. Biol Psychiatry 1999, 46:19-30. 10.1016/S0006-3223(99)00002-5, 10394471.
3. Carta M, Stancampiano R, Tronci E, Collu M, Usiello A, Morelli M, Fadda F. Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats. Neuroscience 2006, 139:1163-72. 10.1016/j.neuroscience.2006.01.027, 16530976.
4. Krezel W, Kastner P, Chambon P. Differential expression of retinoid receptors in the adult mouse central nervous system. Neuroscience 1999, 89:1291-300. 10.1016/S0306-4522(98)00342-X, 10362315.
5. McCaffery PJ, Adams J, Maden M, Rosa-Molinar E. Too much of a good thing: retinoic acid as an endogenous regulator of neural differentiation and exogenous teratogen. Eur J Neurosci 2003, 18:457-72. 10.1046/j.1460-9568.2003.02765.x, 12911743.
6. Jacobs S, Lie DC, DeCicco KL, Shi Y, DeLuca LM, Gage FH, Evans RM. Retinoic acid is required early during adult neurogenesis in the dentate gyrus. Proc Natl Acad Sci USA 2006, 103:3902-7. 10.1073/pnas.0511294103, 1450163, 16505366.
7. Környei Z, Gócza E, Rühl R, Orsolits B, Vörös E, Szabó B, Vágovits B, Madarász E. Astroglia-derived retinoic acid is a key factor in glia-induced neurogenesis. FASEB J 2007, 21:2496-509. 10.1096/fj.06-7756com, 17438145.
8. Clagett-Dame M, McNeill EM, Muley PD. Role of all-trans retinoic acid in neurite outgrowth and axonal elongation. J Neurobiol 2006, 66:739-56. 10.1002/neu.20241, 16688769.
9. Samad TA, Krezel W, Chambon P, Borrelli E. Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family. Proc Natl Acad Sci USA 1997, 94:14349-54. 10.1073/pnas.94.26.14349, 24972, 9405615.
10. Farooqui SM. Induction of adenylate cyclase sensitive dopamine D2-receptors in retinoic acid induced differentiated human neuroblastoma SHSY-5Y cells. Life Sci 1994, 55:1887-93. 10.1016/0024-3205(94)00520-6, 7990648.
11. Wang HF, Liu FC. Regulation of multiple dopamine signal transduction molecules by retinoids in the developing striatum. Neuroscience 2005, 134:97-105. 10.1016/j.neuroscience.2005.04.008, 15939542.
12. Kulikov AV, Rzhaninova AA, Goldshtein DV, Boldyrev AA. Expression of NMDA receptors in multipotent stromal cells of human adipose tissue under conditions of retinoic acid-induced differentiation. Bull Exp Biol Med 2007, 144:626-9. 10.1007/s10517-007-0390-6, 18642726.
13. Pizzi M, Boroni F, Bianchetti A, Moraitis C, Sarnico I, Benarese M, Goffi F, Valerio A, Spano P. Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line. Eur J Neurosci 2002, 16:2342-50. 10.1046/j.1460-9568.2002.02403.x, 12492429.
14. Jelitai M, Schlett K, Varju P, Eisel U, Madarász E. Regulated appearance of NMDA receptor subunits and channel functions during in vitro neuronal differentiation. J Neurobiol 2002, 51:54-65. 10.1002/neu.10049, 11920728.
15. Younkin DP, Tang CM, Hardy M, Reddy UR, Shi QY, Pleasure SJ, Lee VM, Pleasure D. Inducible expression of neuronal glutamate receptor channels in the NT2 human cell line. Proc Natl Acad Sci USA 1993, 90:2174-8. 10.1073/pnas.90.6.2174, 46048, 7681588.
16. Tricklebank MD, Singh L, Oles RJ, Preston C, Iversen SD. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur J Pharmacol 1989, 167:127-35. 10.1016/0014-2999(89)90754-1, 2550253.
17. Liljequist S, Ossowska K, Grabowska-Anden M, Anden NE. Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice. Eur J Pharmacol 1991, 195:55-61. 10.1016/0014-2999(91)90381-Y, 1829683.
18. Manahan-Vaughan D, von Haebler D, Winter C, Juckel G, Heinemann U. A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats. Hippocampus 2008, 18:125-34. 10.1002/hipo.20367, 17924525.
19. Healy DJ, Meador-Woodruff JH. Dopamine receptor gene expression in hippocampus is differentially regulated by the NMDA receptor antagonist MK-801. Eur J Pharmacol 1996, 306:257-64. 10.1016/0014-2999(96)00204-X, 8813639.
20. Wu J, Zou H, Strong JA, Yu J, Zhou X, Xie Q, Zhao G Jin M, Yu L. Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice. Psychopharmacology (Berl) 2005, 177:256-63. 10.1007/s00213-004-1944-1, 15290006.
21. Per E. Response to: Use of the Pup as the Statistical Unit in Developmental Neurotoxicity Studies: Overlooked Model or Poor Research Design?. Toxicological Sciences 2008, 103:411-413.
22. Qi C, Zou H, Zhang R, Zhao G, Jin M, Yu L. Age-related differential sensitivity to MK-801-induced locomotion and stereotypy in C57BL/6 mice. Eur J Pharmacol 2008, 580:161-8. 10.1016/j.ejphar.2007.07.071, 2705961, 18053981.
23. Lever C, Burton S, O'Keefe J. Rearing on hind legs, environmental novelty, and the hippocampal formation. Rev Neurosci 2006, 17:111-33.
24. Daenen EW, Wolterink G, Van Ree JM. Hyperresponsiveness to phencyclidine in animals lesioned in the amygdala on day 7 of life. Implications for an animal model of schizophrenia. Eur Neuropsychopharmacol 2003, 13:273-9. 10.1016/S0924-977X(03)00029-4, 12888187.
25. Du J, Zhou S, Coggeshall RE, Carlton SM. N-methyl-D-aspartate-induced excitation and sensitization of normal and inflamed nociceptors. Neuroscience 2003, 118:547-62. 10.1016/S0306-4522(03)00009-5, 12699789.
26. Jang JH, Kim DW, Sang Nam T, Se Paik K, Leem JW. Peripheral glutamate receptors contribute to mechanical hyperalgesia in a neuropathic pain model of the rat. Neuroscience 2004, 128:169-76. 10.1016/j.neuroscience.2004.06.040, 15450364.
27. Zhang M, Wan C, Ji B, Zhang Z, Zhu H, Tian N, La Y, Huang K, Jiang L, He G, Gao L, Zhao X, Shi Y, Huang G, Feng G, He L. Proteome alteration of U251 human astrocytoma cell after inhibiting retinoic acid synthesis. Mol Cell Biochem 2009, 323:185-93. 10.1007/s11010-008-9978-z, 19089318.
28. Chartoff EH, Marck BT, Matsumoto AM, Dorsa DM, Palmiter RD. Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation. Proc Natl Acad Sci USA 2001, 98:10451-6. 10.1073/pnas.181356498, 56981, 11517332.
29. Delis F, Mitsacos A, Giompres P. Dopamine receptor and transporter levels are altered in the brain of Purkinje Cell Degeneration mutant mice. Neuroscience 2004, 125:255-68. 10.1016/j.neuroscience.2004.01.020, 15051164.
30. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996, 379:606-12. 10.1038/379606a0, 8628395.
31. Ji SJ, Zhuang B, Falco C, Schneider A, Schuster-Gossler K, Gossler A, Sockanathan S. Mesodermal and neuronal retinoids regulate the induction and maintenance of limbinnervating spinal motor neurons. Dev Biol 2006, 297:249-61. 10.1016/j.ydbio.2006.05.015, 16781703.
32. Zetterström RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann TRH. Dopamine neuron agenesis in Nurr1-deficient mice. Science 1997, 276:248-50. 10.1126/science.276.5310.248, 9092472.
33. Cook CD, Newman JL, Winfree JC, Beardsley PM. Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice. Pharmacol Biochem Behav 2004, 77:309-18. 10.1016/j.pbb.2003.11.002, 14751459.
34. Powell CM, Miyakawa T. Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder?. Biol Psychiatry 2006, 59:1198-07. 10.1016/j.biopsych.2006.05.008, 16797265.
35. Bubeníková-Valesová V, Horácek J, Vrajová M, Höschl C. Models of schizophrenia in humans and animals based on inhibition of NMDA receptors. Neurosci Biobehav Rev 2008, 32:1014-23. 10.1016/j.neubiorev.2008.03.012, 18471877.
36. Kesby JP, Burne TH, McGrath JJ, Eyles DW. Developmental vitamin D deficiency alters MK 801-induced hyperlocomotion in the adult rat: An animal model of schizophrenia. Biol Psychiatry 2006, 60:591-6. 10.1016/j.biopsych.2006.02.033, 16697353.
37. Al-Amin HA, Weinberger DR, Lipska BK. Exaggerated MK-801-induced motor hyperactivity in rats with the neonatal lesion of the ventral hippocampus. Behav Pharmacol 2000, 11:269-78.
38. Mohn AR, Gainetdinov RR, Caron MG, Koller BH. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999, 98:427-436. 10.1016/S0092-8674(00)81972-8, 10481908.
39. Rojas P, Joodmardi E, Hong Y, Perlmann T, Ogren SO. Adult mice with reduced Nurr1 expression: an animal model for schizophrenia. Mol Psychiatry 2007, 12:756-66. 10.1038/sj.mp.4001993, 17457314.
40. Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M. Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1239-1247. 10.1016/j.biopsych.2005.02.002, 15949994.